Erratum: Elevated plasma neutrophil elastase concentration is associated with disease activity in patients with thrombotic thrombocytopenic purpura (Thrombosis Research (2014) 133 (616-621) DOI: 10.1016/j.thromres.2014.01.034);Elevated plasma neutrophil elastase concentration is associated with disease activity in patients with thrombotic thrombocytopenic purpura

Thrombosis Research

Volumn 133, Issue 4, 2014, Pages 616-621

  Mikes, Bálint ^a   Sinkovits, György ^a   Farkas, Péter ^a   Csuka, Dorottya ^a   Schlammadinger, Ágota ^b   Rázsó, Katalin ^b   Demeter, Judit ^c   Domján, Gyula ^c   Réti, Marienn ^d   Prohászka, Zoltán ^a  

^a SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

^b UNIVERSITY OF DEBRECEN   (Hungary)

^c SEMMELWEIS UNIVERSITY   (Hungary)

^d Szent Laszlo Hospital   (Hungary)

Author keywords

complement activation; disease activity; elastase; neutrophil granulocyte; Polymorphonuclear leukocyte; thrombotic thrombocytopenic purpura

Indexed keywords

ALTERNATIVE COMPLEMENT PATHWAY C3 C5 CONVERTASE; COMPLEMENT COMPONENT C3A; EDETIC ACID; HEMOGLOBIN; LEUKOCYTE ELASTASE; LEUKOCYTE ELASTASE INHIBITOR; QIA 96; UNCLASSIFIED DRUG; VON WILLEBRAND FACTOR CLEAVING PROTEINASE;

ACUTE DISEASE; ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; COHORT ANALYSIS; COMPLEMENT ACTIVATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE ASSOCIATION; DOUBLE ANTIBODY SANDWICH ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; LEUKOCYTE ACTIVATION; MALE; MIDDLE AGED; PLASMAPHERESIS; PRIORITY JOURNAL; REMISSION; THROMBOCYTE COUNT; THROMBOTIC THROMBOCYTOPENIC PURPURA; YOUNG ADULT; BLOOD; ENZYMOLOGY; NEUTROPHIL;

ADOLESCENT; ADULT; FEMALE; HUMANS; LEUKOCYTE ELASTASE; MALE; MIDDLE AGED; NEUTROPHIL ACTIVATION; NEUTROPHILS; PURPURA, THROMBOTIC THROMBOCYTOPENIC; YOUNG ADULT;

EID: 84896122042     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2016.03.023     Document Type: Erratum

References (35)

1. K. Chapman, M. Seldon, and R. Richards Thrombotic microangiopathies, thrombotic thrombocytopenic purpura, and ADAMTS-13 Semin Thromb Hemost 38 1 2012 47 54
2. W.F. Clark Thrombotic microangiopathy: current knowledge and outcomes with plasma exchange Semin Dial 25 2 2012 214 219
3. J.A. Kremer Hovinga, and B. Lammle Role of ADAMTS13 in the pathogenesis, diagnosis, and treatment of thrombotic thrombocytopenic purpura Hematology Am Soc Hematol Educ Program 2012 2012 610 616
4. H.M. Tsai von Willebrand factor, shear stress, and ADAMTS13 in hemostasis and thrombosis ASAIO J 58 2 2012 163 169
5. Y. Fujimura, M. Matsumoto, A. Isonishi, H. Yagi, K. Kokame, and K. Soejima et al. Natural history of Upshaw-Schulman syndrome based on ADAMTS13 gene analysis in Japan J Thromb Haemost 9 Suppl 1 2011 283 301
6. M. Moatti-Cohen, C. Garrec, M. Wolf, P. Boisseau, L. Galicier, and E. Azoulay et al. Unexpected frequency of Upshaw-Schulman syndrome in pregnancy-onset thrombotic thrombocytopenic purpura Blood 119 2012 5888 5897
7. F. Peyvandi, S. Lavoretano, R. Palla, H.B. Feys, K. Vanhoorelbeke, and T. Battaglioli et al. ADAMTS13 and anti-ADAMTS13 antibodies as markers for recurrence of acquired thrombotic thrombocytopenic purpura during remission Haematologica 93 2008 232 239
8. S. Chaturvedi, D. Carcioppolo, L. Zhang, and K.R. McCrae Management and outcomes for patients with TTP: analysis of 100 cases at a single institution Am J Hematol 2013
9. T. Falter, K.J. Alber, and I. Scharrer Long term outcome and sequelae in patients after acute thrombotic thrombocytopenic purpura episodes Hamostaseologie 33 2 2013 113 120
10. M. Reti, P. Farkas, D. Csuka, K. Razso, A. Schlammadinger, and M.L. Udvardy et al. Complement activation in thrombotic thrombocytopenic purpura J Thromb Haemost 10 2012 791 798
11. 2 Complement activation in thrombotic thrombocytopenic purpura Mol Immunol 56 3 December 15 2013 1
12. Z. Derzsy, Z. Prohaszka, J. Rigo Jr., G. Fust, and A. Molvarec Activation of the complement system in normal pregnancy and preeclampsia Mol Immunol 47 2010 1500 1506
13. T.H. Hung, S.F. Chen, L.M. Lo, M.J. Li, Y.L. Yeh, and T.T. Hsieh Myeloperoxidase in the plasma and placenta of normal pregnant women and women with pregnancies complicated by preeclampsia and intrauterine growth restriction Placenta 33 2012 294 303
14. T.A. Fuchs, J.A. Kremer Hovinga, D. Schatzberg, D.D. Wagner, and B. Lammle Circulating DNA and myeloperoxidase indicate disease activity in patients with thrombotic microangiopathies Blood 120 2012 1157 1164
15. T. Gombos, V. Mako, L. Cervenak, J. Papassotiriou, J. Kunde, and J. Harsfalvi et al. Levels of von Willebrand factor antigen and von Willebrand factor cleaving protease (ADAMTS13) activity predict clinical events in chronic heart failure Thromb Haemost 102 2009 573 580
16. M.D. Walters, I.U. Matthei, R. Kay, M.J. Dillon, and T.M. Barratt The polymorphonuclear leucocyte count in childhood haemolytic uraemic syndrome Pediatr Nephrol 3 1989 130 134
17. N. Ishikawa, H. Kamitsuji, T. Murakami, A. Nakayama, and Y. Umeki Plasma levels of granulocyte elastase-alpha1-proteinase inhibitor complex in children with hemolytic uremic syndrome caused by verotoxin-producing Escherichia coli Pediatr Int 42 2000 637 641
18. M.M. Fitzpatrick, V. Shah, G. Filler, M.J. Dillon, and T.M. Barratt Neutrophil activation in the haemolytic uraemic syndrome: free and complexed elastase in plasma Pediatr Nephrol 6 1992 50 53
19. V. Brinkmann, U. Reichard, C. Goosmann, B. Fauler, Y. Uhlemann, and D.S. Weiss et al. Neutrophil extracellular traps kill bacteria Science 303 2004 1532 1535
20. V. Brinkmann, and A. Zychlinsky Neutrophil extracellular traps: is immunity the second function of chromatin? J Cell Biol 198 5 2012 773 783
21. S.R. Clark, A.C. Ma, S.A. Tavener, B. McDonald, Z. Goodarzi, and M.M. Kelly et al. Platelet TLR4 activates neutrophil extracellular traps to ensnare bacteria in septic blood Nat Med 13 2007 463 469
22. K. Kessenbrock, M. Krumbholz, U. Schonermarck, W. Back, W.L. Gross, and Z. Werb et al. Netting neutrophils in autoimmune small-vessel vasculitis Nat Med 15 2009 623 625
23. C.F. Urban, D. Ermert, M. Schmid, U. Abu-Abed, C. Goosmann, and W. Nacken et al. Neutrophil extracellular traps contain calprotectin, a cytosolic protein complex involved in host defense against Candida albicans PLoS Pathog 5 2009 e1000639
24. V. Papayannopoulos, K.D. Metzler, A. Hakkim, and A. Zychlinsky Neutrophil elastase and myeloperoxidase regulate the formation of neutrophil extracellular traps J Cell Biol 191 2010 677 691
25. S. Massberg, L. Grahl, M.L. von Bruehl, D. Manukyan, S. Pfeiler, and C. Goosmann et al. Reciprocal coupling of coagulation and innate immunity via neutrophil serine proteases Nat Med 16 2010 887 896
26. A. Brill, T.A. Fuchs, A.S. Savchenko, G.M. Thomas, K. Martinod, and S.F. De Meyer et al. Neutrophil extracellular traps promote deep vein thrombosis in mice J Thromb Haemost 10 2012 136 144
27. J. Xu, X. Zhang, R. Pelayo, M. Monestier, C.T. Ammollo, and F. Semeraro et al. Extracellular histones are major mediators of death in sepsis Nat Med 15 2009 1318 1321
28. J. Chen, X. Fu, Y. Wang, M. Ling, B. McMullen, and J. Kulman et al. Oxidative modification of von Willebrand factor by neutrophil oxidants inhibits its cleavage by ADAMTS13 Blood 115 2010 706 712
29. T.J. Raife, W. Cao, B.S. Atkinson, B. Bedell, R.R. Montgomery, and S.R. Lentz et al. Leukocyte proteases cleave von Willebrand factor at or near the ADAMTS13 cleavage site Blood 114 2009 1666 1674
30. J. Leffler, M. Martin, B. Gullstrand, H. Tyden, C. Lood, and L. Truedsson et al. Neutrophil extracellular traps that are not degraded in systemic lupus erythematosus activate complement exacerbating the disease J Immunol 188 2012 3522 3531
31. M.A. Jagels, P.J. Daffern, and T.E. Hugli C3a and C5a enhance granulocyte adhesion to endothelial and epithelial cell monolayers: epithelial and endothelial priming is required for C3a-induced eosinophil adhesion Immunopharmacology 46 3 2000 209 222
32. Q. Peng, K. Li, S.H. Sacks, and W. Zhou The role of anaphylatoxins C3a and C5a in regulating innate and adaptive immune responses Inflamm Allergy Drug Targets 8 2009 236 246
33. M.L. van Montfoort, F. Stephan, M.N. Lauw, B.A. Hutten, G.J. Van Mierlo, and S. Solati et al. Circulating nucleosomes and neutrophil activation as risk factors for deep vein thrombosis Arterioscler Thromb Vasc Biol 33 1 2013 147 151
34. D. Karpman, and R. Tati Complement activation in thrombotic microangiopathy Hamostaseologie 33 2 2013 96 104
35. M. Noris, F. Mescia, and G. Remuzzi STEC-HUS, atypical HUS and TTP are all diseases of complement activation Nat Rev Nephrol 8 11 2012 622 633